Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
November 21, 2011 by · Leave a Comment
Postmenopausal females with osteoporosis or low bone mass who are on Prolia (denosumab) treatment were found to have continued increase in BMD (bone mineral density) for up to eight years, Amgen announced today at the meeting of the American Society for Bone and Mineral Research, San Diego, California…
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
November 14, 2011 by · Leave a Comment
Postmenopausal females with osteoporosis or low bone mass who are on Prolia (denosumab) treatment were found to have continued increase in BMD (bone mineral density) for up to eight years, Amgen announced today at the meeting of the American Society for Bone and Mineral Research, San Diego, California…
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
November 12, 2011 by · Leave a Comment
Postmenopausal females with osteoporosis or low bone mass who are on Prolia (denosumab) treatment were found to have continued increase in BMD (bone mineral density) for up to eight years, Amgen announced today at the meeting of the American Society for Bone and Mineral Research, San Diego, California…
Prolia (Denosumab) Maintains Menopausal Women's Bone Density For Over Eight Years
November 9, 2011 by · Leave a Comment
Postmenopausal females with osteoporosis or low bone mass who are on Prolia (denosumab) treatment were found to have continued increase in BMD (bone mineral density) for up to eight years, Amgen announced today at the meeting of the American Society for Bone and Mineral Research, San Diego, California…
Kemptville District Hospital Opens Digital Mammography Unit
November 7, 2011 by · Leave a Comment
Kemptville District Hospital is now performing digital mammograms to detect very early breast cancer and conducting bone mineral density testing to screen for osteoporosis.
(PRWeb November 04, 2011)
